In the present study, we tested the hypotheses: 1) elevated plasma concentrations of YKL-40 and IL-6 in combination with serum CA 19.9 can be used to diagnose patients with PC; and 2) elevated pre-treatment plasma YKL-40 and IL-6 predict poor prognosis. The gene discussed is IL6; the disease is pachyonychia congenita.